# Mary Falzon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-falzon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,314 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 49 |
| i10-index | 79 |
| Last Known Institution | University College Hospital |
| OpenAlex ID | https://openalex.org/A5038725960 |
| ORCID iD | https://orcid.org/0009-0006-6210-4376 |
| Works | 204 |

## Researcher papers

- [Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution](https://scholariq.org/papers/allele-specific-hla-loss-and-immune-escape-in-lung-cancer-evolution/)
- [Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial](https://scholariq.org/papers/risk-adapted-targeted-intraoperative-radiotherapy-versus-whole-breast/)
- [Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial](https://scholariq.org/papers/targeted-intraoperative-radiotherapy-versus-whole-breast-radiotherapy-for-breast/)
- [Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors](https://scholariq.org/papers/fc-optimized-anti-cd25-depletes-tumor-infiltrating-regulatory-t-cells-and/)
- [The evolution of lung cancer and impact of subclonal selection in TRACERx](https://scholariq.org/papers/the-evolution-of-lung-cancer-and-impact-of-subclonal-selection-in-tracerx/)
- [Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial](https://scholariq.org/papers/long-term-survival-and-local-control-outcomes-from-single-dose-targeted/)
- [Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma](https://scholariq.org/papers/determinants-of-anti-pd-1-response-and-resistance-in-clear-cell-renal-cell/)
- [The evolution of non-small cell lung cancer metastases in TRACERx](https://scholariq.org/papers/the-evolution-of-non-small-cell-lung-cancer-metastases-in-tracerx/)
- [RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy](https://scholariq.org/papers/retracted-article-antibodies-against-endogenous-retroviruses-promote-lung-cancer/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

## Researcher university

- [University College Hospital](https://scholariq.org/institutions/university-college-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.